These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5773815)

  • 1. Reversal of antileukemic action and toxicity of 1-aminocyclopentanecarboxylic acid in mice by L-valine.
    Gregory FJ; Flint SF; Ruelius HW; Warren GH
    Cancer Res; 1969 Mar; 29(3):728-9. PubMed ID: 5773815
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of the toxicity to several cyclopentylamino acid analogs.
    Abshire CJ
    J Med Chem; 1968 May; 11(3):598-9. PubMed ID: 4872872
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of L-valine on renal excretion, blood concentrations and toxicity of cycloleucine in mice.
    Ruelius HW; Gregory FJ; Kirkman SK; Warren GH; Janssen FW
    Biochem Pharmacol; 1973 Jun; 22(11):1379-83. PubMed ID: 4727787
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of in vitro cytotoxic activity of cyclopentanones derivatives].
    Ben Sassi A; Tabka T; Gauduchon P; Dallemagne P; Aouni M
    Tunis Med; 2004 Oct; 82(10):919-26. PubMed ID: 15686188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical note. Phase II study of 1-aminocyclopentanecarboxylic acid (NSC-1026) in patients with cancer.
    Aust JB; Andrews NC; Schroeder JM; Lawton RL
    Cancer Chemother Rep; 1970 Aug; 54(4):237-41. PubMed ID: 4946007
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antisoporific and cardiotropic properties of new amino acid derivatives of nicotinic acid].
    Samvelian VM; Kazarian SA; Dzhanpoladian EG; Matevosian LA
    Farmakol Toksikol; 1986; 49(3):35-7. PubMed ID: 3087769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
    Kline I; Venditti JM; Mead JA; Tyrer DD; Goldin A
    Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. VII.
    Venditti JM; Sheldon DR; Goldin A
    Cancer Res; 1964 Jan; 24(1 Pt 1):145-210. PubMed ID: 5878215
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antileukemic activity of carminomycin complexes with a high-polymer DNA].
    Vaĭnberg IuP; Egorov LV; Kuznetsova TV; Rudneva NA; Khanykova OK
    Antibiotiki; 1980 Jun; 25(6):454-8. PubMed ID: 7396445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular mechanism of the antileukemic action of quinoline dibromide].
    Golenko OD; Paramonova TD; Nikolaeva TG
    Biull Eksp Biol Med; 1984 Jul; 98(7):59-61. PubMed ID: 6466833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
    Karaivanova MH; Zakhariev SG; Golovinsky EV
    Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of benzylpenicillin and doxycycline on toxicity and antineoplastic action of cyclophosphamide and methotrexate in mice].
    Pakulska W
    Acta Pol Pharm; 1992; 49(1-2):35-40. PubMed ID: 8769079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
    Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antileukemic effect of novel dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
    Rauko P; Novotny L; Mego M; Saiko P; Schott H; Szekeres T
    Neoplasma; 2007; 54(1):68-74. PubMed ID: 17203895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileukemic effects of 5-(2-dimethylaminoethoxy)-7-oxo-7H-benzo(c) fluorene, substance VUFB 13 468, on L1210 and La leukemia.
    Pujman V; Cernochová S
    Neoplasma; 1981; 28(6):715-20. PubMed ID: 7339500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-antileukemic activity relationship study of B- and D-ring modified and nonmodified steroidal esters of 4-methyl-3-N,N-bis(2-chloroethyl)amino benzoic acid: a comparative study.
    Fousteris MA; Koutsourea AI; Arsenou ES; Papageorgiou A; Mourelatos D; Nikolaropoulos SS
    Anticancer Drugs; 2007 Oct; 18(9):997-1004. PubMed ID: 17704649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antileukemic activity of combinations of two nitrosoureas.
    Wheeler GP; Schabel FM; Trader MW
    Cancer Treat Rep; 1981; 65(7-8):591-9. PubMed ID: 6454482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effect of lipoic acid and doxorubicin in murine leukemia.
    Dovinová I; Novotný L; Rauko P; Kvasnicka P
    Neoplasma; 1999; 46(4):237-41. PubMed ID: 10613604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antileukemic activity and chemical transformation of the 5'-chloro-5'-deoxy derivative of cyclocytidine.
    Stankovicová M; Rauko P; Bachratá M; Blesová M; Sveda P
    Neoplasma; 1995; 42(5):255-8. PubMed ID: 8552205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel, aminoalkanolic derivatives of 5,7-dihydroxy-2-phenylbenzopyran-4-on as the potential cytostatic agents.
    Mazur A; Balicka E; Zawadowski T; Miks B; Kawiak J
    Mater Med Pol; 1995; 27(4):157-9. PubMed ID: 9000841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.